Abstract
Tracheal tumors are quite rare, and about 90 % are malignant. The two most common malignant tracheal tumors, squamous cell and adenoid cystic carcinomas, have an equal incidence. Less common tumors include mucoepidermoid carcinomas, sarcomas, carcinoids, lymphomas, and melanoma. Common symptoms include dyspnea, cough, hemoptysis, wheeze (or “asthma”), stridor, and hoarseness. Distant metastases are rare.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Introduction
Tracheal tumors are quite rare, and about 90 % are malignant. The two most common malignant tracheal tumors, squamous cell and adenoid cystic carcinomas, have an equal incidence. Less common tumors include mucoepidermoid carcinomas, sarcomas, carcinoids, lymphomas, and melanoma (Gaissert et al. 2004, 2006). Common symptoms include dyspnea, cough, hemoptysis, wheeze (or “asthma”), stridor, and hoarseness. Distant metastases are rare.
Initial evaluation is with chest radiography, followed by contrast-enhanced chest CT with multiplane reconstruction. The degree of obstruction can be assessed accurately with CT. An estimate of the extent of longitudinal spread, the most important factor in determining resectability, also may be ascertained by reviewing the CT scan. Bronchoscopy, the next step, is performed for biopsy; assessment of lesion length, submucosal spread, and length of normal trachea; and relief of obstruction, if necessary. Rigid bronchoscopy is preferred for generous biopsy specimens and for relief of obstruction. Obstructing tumors typically are débrided endoscopically, and the base is treated with YAG (yttrium-aluminium-garnet) laser to reduce bleeding. Definitive resection rarely is emergent, as obstruction usually is relieved easily by bronchoscopic means.
Most patients who present with a tracheal tumor can undergo resection by an experienced airway surgeon (Gaissert et al. 2009). Resection length less than 4 cm is a favorable finding, but occasionally tumors up to 6 cm long may be resected if the patient is otherwise an excellent candidate. Factors affecting resectability include tumor length, body habitus, neck mobility and length, invasion of adjacent structures, metastatic disease (rare), age, and comorbid factors. The ideal patient is young, thin, and flexible with a long neck. Through experience, surgeons learn to what extent the negative prognostic factors influence how much of the trachea can be resected safely. Previous radiation therapy and resection are strong negative factors when considering resection. If patients are started on steroids for airway obstruction, they should be tapered off quickly and the resection done off steroids. Currently, there rarely is a role for preoperative induction therapy.
Tumors in the upper third of the trachea are approached by a cervical collar incision, those in the middle third by a combined cervical and mediastinal incision (a collar incision followed by a partial upper sternotomy), and those in the lower third usually by a right thoracotomy on top of the fifth rib. Occasionally, I resect long tumors extending down close to the carina by a full sternotomy so that bilateral hilar releases can be done, realizing access to the anastomosis will be somewhat challenging.
Patients are informed of the probable need for adjuvant radiation therapy after satisfactory recovery from tracheal resection. Patients with close or positive margins usually are referred for adjuvant radiation after control bronchoscopy 1 or 2 months after resection has demonstrated a well-healed anastomosis.
Conclusion
In our series, about 70 % of malignant tumors and almost all benign tumors were resectable (Gaissert et al. 2004; Honings et al. 2010). About 40 % of patients with malignant tumors had microscopic positive margins, and around 20 % had positive lymph nodes. Recent perioperative mortality has been about 3 %. Anastomotic complications occurred in 15 % of patients. Five-year survival was 39 % in patients with resected squamous cell carcinoma but only 7 % in those with unresected tumors. Five-year survival was 52 % in patients with resected adenoid cystic carcinoma, 33 % in those with unresected disease. Complete resection was a favorable prognostic factor. Disease-free survival was significantly longer after resection in patients with negative airway margins and no extramural disease, perineural growth (adenoid cystic carcinoma), or lymph node metastases. Adenoid cystic carcinomas may recur very late, so these patients must be followed up for the rest of their lives.
The most important aspect of the initial evaluation of a patient with a tracheal tumor is the resectability of the tumor, which primarily is a function of the length of involvement of the trachea. Knowing the tumor’s pathology helps determine resectability, as adenoid cystic carcinomas almost always have more extensive submucosal and perineural spread than is readily apparent. This aspect of the tumor’s biology must be recognized when deciding whether to resect an already long lesion, as it is always worse in the operating room at tracheal division. Tumors up to 4 cm almost always can be resected, but caution must be used when that length is exceeded. A good general rule to follow in the operating room is that if the resection is long and the surgeon is thinking about performing a hilar or suprahyoid release, he or she should do it. With longer resections, only experience can help guide the surgeon as to what is possible in his or her attempt to gauge anastomotic tension before committing to the resection.
Selected Bibliography
Gaissert HA, Grillo HC, Shadmehr MB et al (2004) Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. J Thorac Cardiovasc Surg 78:1889–1897
Gaissert HA, Grillo HC, Shadmehr MB et al (2006) Uncommon primary tracheal tumors. Ann Thorac Surg 82:268–273
Gaissert HA, Honings J, Gokhale M (2009) Treatment of tracheal tumors. Semin Thorac Cardiovasc Surg 21:290–295
Honings J, Gaissert HA, Weinberg AC (2010) Prognostic value of pathologic characteristics and resection margins in tracheal adenoid cystic carcinoma. Eur J Cardiothorac Surg 37:1438–1444
Montgomery WW (1974) Suprahyoid release for tracheal anastomosis. Acta Otolaryngol 99:255–260
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wright, C.D. (2015). Malignant Tracheal Tumors. In: Dienemann, H., Hoffmann, H., Detterbeck, F. (eds) Chest Surgery. Springer Surgery Atlas Series. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12044-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-12044-2_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12043-5
Online ISBN: 978-3-642-12044-2
eBook Packages: MedicineMedicine (R0)